These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 23070146)
1. Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers. Yin OQ; Bédoucha V; McCulloch T; Zheng C; Zhou W; Hussaini A; Novick S Cancer Chemother Pharmacol; 2013 Jan; 71(1):219-26. PubMed ID: 23070146 [TBL] [Abstract][Full Text] [Related]
2. Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects. Eley T; Luo FR; Agrawal S; Sanil A; Manning J; Li T; Blackwood-Chirchir A; Bertz R J Clin Pharmacol; 2009 Jun; 49(6):700-9. PubMed ID: 19395585 [TBL] [Abstract][Full Text] [Related]
3. Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers. Tawbi HA; Tran AL; Christner SM; Lin Y; Johnson M; Mowrey E; Appleman LR; Stoller R; Miller BM; Egorin MJ; Beumer JH Cancer Chemother Pharmacol; 2013 Nov; 72(5):1143-7. PubMed ID: 24036846 [TBL] [Abstract][Full Text] [Related]
4. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib. Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766 [TBL] [Abstract][Full Text] [Related]
5. The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics. Martin PD; Schneck DW; Dane AL; Warwick MJ Curr Med Res Opin; 2008 Apr; 24(4):1231-5. PubMed ID: 18355422 [TBL] [Abstract][Full Text] [Related]
6. Effects of nilotinib on single-dose warfarin pharmacokinetics and pharmacodynamics: a randomized, single-blind, two-period crossover study in healthy subjects. Yin OQ; Gallagher N; Fischer D; Zhao L; Zhou W; Leroy E; Golor G; Schran H Clin Drug Investig; 2011; 31(3):169-79. PubMed ID: 21184622 [TBL] [Abstract][Full Text] [Related]
7. Effects of yogurt and applesauce on the oral bioavailability of nilotinib in healthy volunteers. Yin OQ; Rudoltz M; Galetic I; Filian J; Krishna A; Zhou W; Custodio J; Golor G; Schran H J Clin Pharmacol; 2011 Nov; 51(11):1580-6. PubMed ID: 21712497 [TBL] [Abstract][Full Text] [Related]
8. Impaired bioavailability of famotidine given concurrently with a potent antacid. Barzaghi N; Gatti G; Crema F; Perucca E J Clin Pharmacol; 1989 Jul; 29(7):670-2. PubMed ID: 2569486 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers. Stass H; Böttcher MF; Ochmann K Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity. Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722 [TBL] [Abstract][Full Text] [Related]
11. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers. Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids. Auclair B; Nix DE; Adam RD; James GT; Peloquin CA Antimicrob Agents Chemother; 2001 Mar; 45(3):810-4. PubMed ID: 11181366 [TBL] [Abstract][Full Text] [Related]
14. Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers. Yasuda S; Higashi S; Murakami M; Tomono Y; Kawaguchi M Int J Clin Pharmacol Ther; 1999 May; 37(5):249-53. PubMed ID: 10363624 [TBL] [Abstract][Full Text] [Related]
15. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies. Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149 [TBL] [Abstract][Full Text] [Related]
16. Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids. Snell P; Oo C; Dorr A; Barrett J Br J Clin Pharmacol; 2002 Oct; 54(4):372-7. PubMed ID: 12392584 [TBL] [Abstract][Full Text] [Related]
17. Effects of antacids and food on absorption of famotidine. Lin JH; Chremos AN; Kanovsky SM; Schwartz S; Yeh KC; Kann J Br J Clin Pharmacol; 1987 Oct; 24(4):551-3. PubMed ID: 2891370 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial. Feldman M JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369 [TBL] [Abstract][Full Text] [Related]
19. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir. Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833 [TBL] [Abstract][Full Text] [Related]
20. Short report: a comparative study of the interaction between antacid and H2-receptor antagonists. Sullivan TJ; Reese JH; Jauregui L; Miller K; Levine L; Bachmann KA Aliment Pharmacol Ther; 1994 Feb; 8(1):123-6. PubMed ID: 7910488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]